Solventum (SOLV) Revenue & Revenue Breakdown
Solventum Revenue Highlights
Latest Revenue (Y)
$8.32B
Latest Revenue (Q)
$2.10B
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Solventum Revenue by Period
Solventum Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $8.32B | 0.86% |
| 2024-12-31 | $8.25B | 0.70% |
| 2023-12-31 | $8.20B | 0.82% |
| 2022-12-31 | $8.13B | -0.50% |
| 2021-12-31 | $8.17B | 12.22% |
| 2020-12-31 | $7.28B | - |
Solventum generated $8.32B in revenue during NA 2025, up 0.86% compared to the previous quarter, and up 114.34% compared to the same period a year ago.
Solventum Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $2.10B | -3.01% |
| 2025-06-30 | $2.16B | 4.40% |
| 2025-03-31 | $2.07B | -0.24% |
| 2024-12-31 | $2.08B | -0.34% |
| 2024-09-30 | $2.08B | 0.05% |
| 2024-06-30 | $2.08B | 3.22% |
| 2024-03-31 | $2.02B | -3.77% |
| 2023-12-31 | $2.10B | 1.01% |
| 2023-09-30 | $2.07B | -0.10% |
| 2023-06-30 | $2.08B | 3.23% |
| 2023-03-31 | $2.01B | 2.08% |
| 2022-12-31 | $1.97B | -1.94% |
| 2022-09-30 | $2.01B | -2.38% |
| 2022-06-30 | $2.06B | - |
| 2022-03-31 | $2.06B | - |
Solventum generated $2.10B in revenue during Q3 2025, up -3.01% compared to the previous quarter, and up 100.72% compared to the same period a year ago.
Solventum Revenue Breakdown
Solventum Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 |
|---|---|---|
| Product | $6.35B | $6.35B |
Latest
Solventum's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 |
|---|---|---|---|---|---|---|---|
| Product | $1.49B | $1.59B | $1.67B | $1.60B | $3.13B | $1.61B | $1.60B |
Latest
Solventum's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).
Solventum Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 |
|---|---|---|
| UNITED STATES | $4.67B | $4.75B |
| Non-US | $3.66B | $3.50B |
Latest
Solventum's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (56.07%), and Non-US (43.93%).
Solventum Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RDY | Dr. Reddy's Laboratories | $279.16B | - |
| UHS | Universal Health Services | $17.36B | $4.50B |
| SOLV | Solventum | $8.32B | $2.10B |
| ICLR | ICON Public | $8.12B | $2.09B |
| EHC | Encompass Health | $5.94B | $1.48B |
| ENSG | Ensign Group | $5.06B | $1.30B |
| ELAN | Elanco Animal Health | $4.71B | $1.14B |
| ALGN | Align | $4.03B | $995.69M |
| RVTY | Revvity | $2.86B | $698.95M |
| QGEN | Qiagen | $1.97B | $458.80M |
| DOCS | Doximity | $570.40M | $185.05M |